Subscribe To
Is spdr s&p pharmaceuticals etf (xph) a strong etf right now?
Smart Beta ETF report for XPH...
January 27, 2022, 7:43 am
Vertex pharmaceuticals, inc. (vrtx) ceo reshma kewalramani on q4 2021 results - earnings call transcript
Vertex pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q4 2021 Results - Earnings Call Transcrip...
January 26, 2022, 9:31 pm
Vertex pharmaceuticals, inc. (vrtx) ceo reshma kewalramani on q4 2021 results - earnings call transcript
Vertex pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q4 2021 Results - Earnings Call Transcrip...
January 26, 2022, 9:31 pm
Vertex pharmaceuticals, inc. (vrtx) ceo reshma kewalramani on q4 2021 results - earnings call transcript
Vertex pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q4 2021 Results - Earnings Call Transcrip...
January 26, 2022, 9:31 pm
Vertex pharmaceuticals (vrtx) surpasses q4 earnings and revenue estimates
Vertex (VRTX) delivered earnings and revenue surprises of 2.74% and 4.01%, respectively, for the quarter ended December 2021. Do the numbers hold clue...
January 26, 2022, 6:25 pm
Vertex pharmaceuticals (vrtx) surpasses q4 earnings and revenue estimates
Vertex (VRTX) delivered earnings and revenue surprises of 2.74% and 4.01%, respectively, for the quarter ended December 2021. Do the numbers hold clue...
January 26, 2022, 6:25 pm
Vertex pharmaceuticals (vrtx) surpasses q4 earnings and revenue estimates
Vertex (VRTX) delivered earnings and revenue surprises of 2.74% and 4.01%, respectively, for the quarter ended December 2021. Do the numbers hold clue...
January 26, 2022, 6:25 pm
Biondvax to present at edison group's open house conference
JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax pharmaceuticals Ltd. (Nasdaq: BVXV), a bio...
January 26, 2022, 7:39 am
Biondvax to present at edison group's open house conference
JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax pharmaceuticals Ltd. (Nasdaq: BVXV), a bio...
January 26, 2022, 7:39 am
Biondvax to present at edison group's open house conference
JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax pharmaceuticals Ltd. (Nasdaq: BVXV), a bio...
January 26, 2022, 7:39 am
Johnson & johnson readies to spin off business units as covid effects linger in 2022
Moving to split its consumer health and medical device/pharma units into two separate public companies, the Johnson & Johnson (JNJ) version of “divi...
January 25, 2022, 1:35 pm
Johnson & johnson readies to spin off business units as covid effects linger in 2022
Moving to split its consumer health and medical device/pharma units into two separate public companies, the Johnson & Johnson (JNJ) version of “divi...
January 25, 2022, 1:35 pm
Johnson & johnson readies to spin off business units as covid effects linger in 2022
Moving to split its consumer health and medical device/pharma units into two separate public companies, the Johnson & Johnson (JNJ) version of “divi...
January 25, 2022, 1:35 pm
Andreas halvorsen gets in on amylyx pharmaceuticals' ipo
Andreas Halvorsen (Trades, Portfolio), chief investment officer of Viking Global Investors, disclosed a stake in Amylyx ...
January 25, 2022, 12:59 pm
Andreas halvorsen gets in on amylyx pharmaceuticals' ipo
Andreas Halvorsen (Trades, Portfolio), chief investment officer of Viking Global Investors, disclosed a stake in Amylyx ...
January 25, 2022, 12:59 pm
Andreas halvorsen gets in on amylyx pharmaceuticals' ipo
Andreas Halvorsen (Trades, Portfolio), chief investment officer of Viking Global Investors, disclosed a stake in Amylyx ...
January 25, 2022, 12:59 pm
Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain
RespireRx pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have pu...
January 25, 2022, 8:43 am
Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain
RespireRx pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have pu...
January 25, 2022, 8:43 am
Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain
RespireRx pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have pu...
January 25, 2022, 8:43 am
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical...
January 25, 2022, 8:43 am